Amygdala Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for ANS-858
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Tue, 18 August 2026
What it is about
Brent BlackburnDrug AdministrationGe HealthcareAmygdala Neurosciences IncRapiscan Pharma SolutionsFoundation For Alcohol ResearchCompany Investigational New Drug
Who published it, and when
How it spread - 1 original report
Tue, 18 August 2026
1 report- bubblear.com07:00first to report
ANS-858 is being developed to reduce pathological craving associated with alcohol and other substance use disorders.Amygdala's ALDH2 inhibitor platform offers additional therapeutic opportunities in b